caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1518258755

David KennedyM.D.

OphthalmologyMetairie, LAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
Final MIPS score
75.0
Quality
0.0
Cost
0.0
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
0.00%
Group
REFERRAL NETWORK

Where David Kennedy's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Kamel Itani
Ophthalmology · Dallas, TX
30104
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
2,612
Beneficiaries
—
Total drug cost
$253K
Distinct drugs
28
Brand share
29.4%
Top prescribed drugs
Prednisolone Acetate562 claims
Latanoprost560 claims
Ofloxacin320 claims
Dorzolamide Hcl/Timolol Maleat199 claims
Cyclosporine123 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$1K
Payment records
54
By payment type
Food and Beverage$1K
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,382
Unique beneficiaries
—
Total services
1,710
Distinct HCPCS
16
Medicare payment
$142K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 255 Ophthalmology providers in LA — above median (cohort median 1,801).